• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
ReportsnReports – VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2011
 

ReportsnReports – VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2011

on

  • 365 views

Vascular Endothelial Growth Factor (VEGF), which plays an important role in angiogenesis, has been extensively studied and over-expression is seen in many cancers. Today, VEGF is targeted using ...

Vascular Endothelial Growth Factor (VEGF), which plays an important role in angiogenesis, has been extensively studied and over-expression is seen in many cancers. Today, VEGF is targeted using antibodies and tyrosine kinase inhibitors, and antiangiogenic therapy is a standard treatment for many cancers, including colorectal and non-small cell lung cancer.

Statistics

Views

Total Views
365
Views on SlideShare
365
Embed Views
0

Actions

Likes
0
Downloads
5
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    ReportsnReports – VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2011 ReportsnReports – VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2011 Document Transcript